Instituto De Investigación Biomédica De Salamanca

This study tests a treatment called TranspoCART19 for people with B-cell lymphoma that has returned or not responded to standard therapy. The treatment uses a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The main goals are t…

This study follows 400 adults with long COVID for four years to understand how the condition changes over time. Researchers will measure fatigue, blood vessel health, and biological markers to find patterns that could lead to better diagnosis and personalized care. The goal is to…